We have previously shown that administration of anti-FGFR4 prevents the development of LVH in the 5/6 nephrectomy rat model of CKD11, indicating that FGF23/FGFR4 is important for the initiation of cardiac hypertrophy in the context of kidney injury. The gene discussed is FGF23; the disease is cardiac hypertrophy.